Analytical Data
-
Gene name
SSTR5
- Application
-
Alternative Names
(SS-5-R)(SS5-R)(SS5R)(SST5)
-
Species
Human
-
Source
E. coli
-
Tag
C- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P35346
-
Expression Region
307-364aa
-
Molecular Weight
8.0 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SSTR5, or somatostatin receptor type 5, is a member of the somatostatin receptor family that plays a crucial role in numerous physiological processes, including neuroendocrine regulation and cell proliferation. Research into SSTR5 is significant because of its implications in various pathologies such as neuroendocrine tumors and metabolic disorders. The receptor is primarily involved in the inhibition of hormone secretion and neurotransmitter release, influencing processes like insulin regulation and growth hormone dynamics. Given its role in tumor biology, SSTR5 serves as a promising therapeutic target, especially in the management of conditions such as acromegaly and carcinoid syndrome, where aberrant somatostatin signaling is common. The development of recombinant SSTR5 proteins has paved the way for advanced studies on receptor structure, function, and interaction with ligands. Understanding the molecular characteristics and signaling pathways associated with SSTR5 can offer insights into designing targeted therapies and enhancing drug delivery systems. Consequently, ongoing research into SSTR5 recombinant proteins is vital for identifying novel treatment strategies and improving clinical outcomes for patients with related disorders.
